Clinical Trials Browser

Phase 2 × Lung Neoplasms × Aprepitant × Clear all

NCT02445872 2015-12-09

Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy

Phase 2 Unknown

Lung Neoplasms, Nausea, Vomiting